[go: up one dir, main page]

FI924869L - Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa - Google Patents

Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa

Info

Publication number
FI924869L
FI924869L FI924869A FI924869A FI924869L FI 924869 L FI924869 L FI 924869L FI 924869 A FI924869 A FI 924869A FI 924869 A FI924869 A FI 924869A FI 924869 L FI924869 L FI 924869L
Authority
FI
Finland
Prior art keywords
dessa
kinolinderivat
anvaendning
therapeutic
och
Prior art date
Application number
FI924869A
Other languages
English (en)
Other versions
FI924869A0 (fi
Inventor
Gerard Cremer
Pascale Goberville
Jean-Claude Muller
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9418349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI924869(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI924869A0 publication Critical patent/FI924869A0/fi
Publication of FI924869L publication Critical patent/FI924869L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Communication Cables (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI924869A 1991-10-28 1992-10-27 Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa FI924869L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113240A FR2683819B1 (fr) 1991-10-28 1991-10-28 Derives de quinoleine, leur procede de preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
FI924869A0 FI924869A0 (fi) 1992-10-27
FI924869L true FI924869L (fi) 1993-04-29

Family

ID=9418349

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924869A FI924869L (fi) 1991-10-28 1992-10-27 Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa

Country Status (18)

Country Link
EP (1) EP0540400B1 (fi)
JP (1) JPH05239053A (fi)
KR (1) KR930007935A (fi)
CN (1) CN1073171A (fi)
AT (1) ATE126798T1 (fi)
AU (1) AU651740B2 (fi)
CA (1) CA2081537A1 (fi)
CZ (1) CZ324292A3 (fi)
DE (1) DE69204252T2 (fi)
FI (1) FI924869L (fi)
FR (1) FR2683819B1 (fi)
HU (1) HUT62883A (fi)
IL (1) IL103568A0 (fi)
MX (1) MX9206169A (fi)
NO (1) NO924138L (fi)
NZ (1) NZ244892A (fi)
PL (1) PL296369A1 (fi)
ZA (1) ZA928297B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478832A (en) * 1992-05-08 1995-12-26 The Green Cross Corporation Quinoline compounds
IT1255461B (it) * 1992-07-28 1995-11-02 Luso Farmaco Inst Eteri di imidazoli ad attivita' a ii antagonista
FR2699174B1 (fr) * 1992-12-14 1995-01-20 Synthelabo Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one, leur préparation et leur application en thérapeutique.
FR2710914B1 (fr) * 1993-10-04 1995-11-24 Synthelabo Dérivés de 2-[2-(tétrazol-5-yl)phényl]-1,2-dihydroquinoléine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2716196B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.
JPH09202774A (ja) 1996-01-25 1997-08-05 Green Cross Corp:The ２−アリールキノリン類およびその製造方法
DE19706161A1 (de) * 1997-02-17 1998-08-20 Oswald Hartmut Prof Dr Med Verwendung von Cyaninen, Isocyaninen und Pseudoisocyaninen als Diuretika
KR100744826B1 (ko) * 2006-04-05 2007-08-01 한국화학연구원 이미다졸기가 치환된 퀴놀리논 유도체
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103804349A (zh) * 2012-11-01 2014-05-21 杨子娇 一类治疗青光眼的化合物及其用途
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
CN108558750B (zh) * 2018-07-11 2021-01-05 武汉工程大学 无溶剂法合成3-硝基喹啉衍生物的工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
ES2101824T3 (es) * 1991-08-15 1997-07-16 Ciba Geigy Ag N-acil-n-heterociclil-onaftalenil-alquil-aminoacidos como antagonistas de angiotensina ii.

Also Published As

Publication number Publication date
ATE126798T1 (de) 1995-09-15
CN1073171A (zh) 1993-06-16
EP0540400B1 (fr) 1995-08-23
NO924138L (no) 1993-04-29
HUT62883A (en) 1993-06-28
CZ324292A3 (en) 1993-09-15
MX9206169A (es) 1993-07-01
FR2683819B1 (fr) 1994-02-11
FR2683819A1 (fr) 1993-05-21
AU651740B2 (en) 1994-07-28
CA2081537A1 (en) 1993-04-29
DE69204252T2 (de) 1996-04-18
EP0540400A1 (fr) 1993-05-05
PL296369A1 (en) 1993-05-31
AU2734892A (en) 1993-04-29
IL103568A0 (en) 1993-03-15
NZ244892A (en) 1994-06-27
JPH05239053A (ja) 1993-09-17
DE69204252D1 (de) 1995-09-28
HU9203374D0 (en) 1993-01-28
ZA928297B (en) 1993-05-07
KR930007935A (ko) 1993-05-20
NO924138D0 (no) 1992-10-27
FI924869A0 (fi) 1992-10-27

Similar Documents

Publication Publication Date Title
FI924069L (fi) Terapeutiskt anvaendbara peptider och peptidfragment
FI935795L (fi) Ctl4a-receptor, fusionsproteiner innehaollande denna och anvaendningar daerav
FI923337L (fi) Organiska fluorenylmetallfoereningar, framstaellning och anvaendning daerav
FI922977L (fi) Heterocykliska foereningar, deras framstaellning och anvaendning
FI923366L (fi) 5-lediga heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI923960L (fi) 5-ledad heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI921030L (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI923691L (fi) Cykliska iminoderivat, dessa foereningar innehaollande farmaceutiska blandningar och foerfarande foer deras framstaellning
FI924687L (fi) Heterobiarylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI923775L (fi) 2-piperazinonfoereningar, deras framstaellning och anvaendning
FI921943L (fi) Poroest bikaksmaterial, foerfarande foer framstaellning av det och anvaendning av det
FI934426L (fi) Tiazolidindionderivat, framstaellning och anvaendning daerav
FI924084L (fi) Tramadol-n-oxidmaterial, enantiomerer och kompositioner daerav och deras anvaendning
FI923143L (fi) Homogeniska, stabila och flytande vattenblandningar och anvaendning av naemnda blandningar foer framstaellning av dispersioner av i vatten oloesliga substanser
FI923947A (fi) Foerfarande foer pulsbreddsmodulation foer oekad linearitet, minskad kommutationsfoerlust och oekad utspaenning i en vaexelriktare/omriktare
FI925924L (fi) Hydrerat staerkelsehydrolysat med laog kariesframkallande effekt, foerfarande foer framstaellning av detta och tillaempningen av detta hydrolysat
FI922983L (fi) Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
FI921049L (fi) Hydrazonderivat, deras framstaellning och anvaendning
FI924869L (fi) Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa
FI920732L (fi) 2-substituerade kinoliner, foerfarande foer framstaellning av dessa och anvaendning av dessa i laekemedel
FI922982L (fi) 2-aminopyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
FI925501L (fi) Imidazolfoereningar, deras framstaellning och anvaendning
FI922390L (fi) Initiatorsuspensioner, deras framstaellning och anvaendning
FI923755L (fi) Disulfider, foerfarande foer framstaellning av dessa och anvaendning av dessa
FI934680L (fi) Arylmorfolin, framstaellning och anvaending

Legal Events

Date Code Title Description
FD Application lapsed